Access the full text.
Sign up today, get DeepDyve free for 14 days.
(1988)
Development of basal ganglia - specific phosphoproteins in reaggregate cultures of the mouse caudatoputamen
H. Hall, M. Sällemark (1987)
Effects of chronic neuroleptic treatment on agonist affinity states of the dopamine-D2 receptor in the rat brain.Pharmacology & toxicology, 60 5
H. Hemmings, A. Nairn, P. Greengard (1984)
DARPP-32, a dopamine- and adenosine 3':5'-monophosphate-regulated neuronal phosphoprotein. II. Comparison of the kinetics of phosphorylation of DARPP-32 and phosphatase inhibitor 1.The Journal of biological chemistry, 259 23
(1987)
Neuronal phosphoproteins . Mediators of signal transduction
H. Hemmings, P. Greengard (1986)
DARPP-32, a dopamine- and adenosine 3':5'-monophosphate-regulated phosphoprotein: regional, tissue, and phylogenetic distribution, 6
(1990)
Rat DARPP32: cloning, sequencing, and characterization
S. Walaas, D. Aswad, D. Aswad, P. Greengard (1983)
A dopamine- and cyclic AMP-regulated phosphoprotein enriched in dopamine-innervated brain regionsNature, 301
(1984)
1984b) DARPP-32, a dopamine-regulated neuronal phosphoprotein
J. Sambrook, E. Fritsch, T. Maniatis (2001)
Molecular Cloning: A Laboratory Manual
S. Walaas, A. Nairn, P. Greengard (1983)
Regional distribution of calcium- and cyclic adenosine 3':5'- monophosphate-regulated protein phosphorylation systems in mammalian brain. I. Particulate systems, 3
(1984)
DARPP32, a dopamine and adenosine
(1983)
Laboratory methods: a method for isolation of intact
J. Girault, H. Hemmings, Kenneth Williams, A. Nairn, P. Greengard (1989)
Phosphorylation of DARPP-32, a dopamine- and cAMP-regulated phosphoprotein, by casein kinase II.The Journal of biological chemistry, 264 36
H. Hemmings, P. Greengard, H. Tung, P. Cohen (1984)
DARPP-32, a dopamine-regulated neuronal phosphoprotein, is a potent inhibitor of protein phosphatase-1Nature, 310
G. Duncan, H. Criswell, T. McCown, I. Paul, R. Mueller, G. Breese (1987)
Behavioral and neurochemical responses to haloperidol and SCH-23390 in rats treated neonatally or as adults with 6-hydroxydopamine.The Journal of pharmacology and experimental therapeutics, 243 3
E. Hess, L. Albers, H. Le, I. Creese (1986)
Effects of chronic SCH23390 treatment on the biochemical and behavioral properties of D1 and D2 dopamine receptors: potentiated behavioral responses to a D2 dopamine agonist after selective D1 dopamine receptor upregulation.The Journal of pharmacology and experimental therapeutics, 238 3
Hemmings Hemmings, Nairn Nairn, Greengard Greengard (1984a)
DARPP‐32, a dopamine and adenosine 3′:5′‐monophosphate‐regulated phosphoprotein enriched in dopamine‐innervated brain regions. II. Comparison of the kinetics of phosphorylation of DARPP‐32 and phosphatase inhibitor 1J. Biol. Chem., 259
(1988)
Development of basal gangliaspecific phosphoproteins in reaggregate cultures
(1982)
Molecular Cloning: A Laboratory Manual, pp. 329-335
A. Feinberg, B. Vogelstein (1983)
A technique for radiolabeling DNA restriction endonuclease fragments to high specific activity.Analytical biochemistry, 132 1
(1986)
Effects of chronic SCH-23390 treatment on the biochemical and behavioral properties of D, and D2
G. Cathala, J. Savouret, Bernardita Méndez, B. West, M. Karin, J. Martial, J. Baxter (1983)
A method for isolation of intact, translationally active ribonucleic acid.DNA, 2 4
Ehrlich Ehrlich, Kurihara Kurihara, Greengard Greengard (1990)
Rat DARPP‐32: cloning, sequencing, and characterization of the cDNAJ. Mol. Neurosci.
H. Hemmings, S. Walaas, C. Ouimet, P. Greengard (1987)
Dopaminergic regulation of protein phosphorylation in the striatum: DARPP-32Trends in Neurosciences, 10
(1986)
DARPP-32, a dopa
(1984)
Addendum: a technique for radiolabeling DNA restriction endonuclease fragments to high specific activity
J. Girault, R. Raisman‐Vozari, Y. Agid, P. Greengard (1989)
Striatal phosphoproteins in Parkinson disease and progressive supranuclear palsy.Proceedings of the National Academy of Sciences of the United States of America, 86 7
Cathala Cathala, Savouret Savouret, Mendez Mendez, West West, Karin Karin, Martial Martial, Baxter Baxter (1983)
Laboratory methods: a method for isolation of intact, translationally active ribonucleic acidDNA, 2
S. Walaas, A. Nairn, P. Greengard (1983)
Regional distribution of calcium- and cyclic adenosine 3':5'- monophosphate-regulated protein phosphorylation systems in mammalian brain. II. Soluble systems, 3
Abstract: DARPP‐32 (dopamine‐ and cyclic AMP‐regulated phosphoprotein, Mr= 32,000, as determined by sodium dodecyl sulfate‐polyacrylamide gel electrophoresis) is a neuronal phosphoprotein that is enriched in neurons which possess dopamine D1 receptors, particularly striatonigral neurons. In rat brain slices, the phosphorylation state of DARPP‐32 is regulated by dopamine, acting through the dopamine D1 receptor and the adenylyl cyclase system. This study reports that chronic blockade (21 days) of either dopamine D1 receptors by SCH‐23390 or dopamine D2 receptors by raclopride does not affect the concentrations of DARPP‐32 in specific rat brain regions (striatum, thalamus, hippocampus, frontal cerebral cortical pole). Northern blot analysis indicates that the steady‐state level of DARPP‐32 mRNA in striatum is also unchanged by these treatments.
Journal of Neurochemistry – Wiley
Published: Jul 1, 1990
Read and print from thousands of top scholarly journals.
Already have an account? Log in
Bookmark this article. You can see your Bookmarks on your DeepDyve Library.
To save an article, log in first, or sign up for a DeepDyve account if you don’t already have one.
Copy and paste the desired citation format or use the link below to download a file formatted for EndNote
Access the full text.
Sign up today, get DeepDyve free for 14 days.
All DeepDyve websites use cookies to improve your online experience. They were placed on your computer when you launched this website. You can change your cookie settings through your browser.